Australian Pharmaceutical Industries SWOT Analysis, Competitors & USP
SWOT analysis of Australian Pharmaceutical Industries analyses the brand by its strengths, weaknesses, opportunities & threats. In Australian Pharmaceutical Industries SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like Australian Pharmaceutical Industries to benchmark its business & performance as compared to the competitors. Australian Pharmaceutical Industries is one of the leading brands in the pharma and healthcare sector.
The table below lists the Australian Pharmaceutical Industries SWOT (Strengths, Weaknesses, Opportunities, Threats), top Australian Pharmaceutical Industries competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).
| Australian Pharmaceutical Industries Brand Analysis | |
|---|---|
| Parent Company |
Australian Pharmaceutical Industries |
| Category |
Pharmaceuticals |
| Sector | |
| Tagline/ Slogan |
- |
| USP |
API is Australia's largest wholesale distributor of pharmaceutical and allied products. |
| Australian Pharmaceutical Industries STP | |
| Segment |
People who looking for quality drugs for health and beauty purposes. |
| Target Group |
Healthcare professionals, wholesalers, generic distributors, and hospitals |
| Positioning |
API is involved in pharmaceutical distribution, retailing and manufacturing of health and beauty products. |
| SWOT Analysis of Australian Pharmaceutical Industries | |
| Australian Pharmaceutical Industries Strengths |
Below are the Strengths in the SWOT Analysis of Australian Pharmaceutical Industries: 1. Offers a broad range of pharmacy services, including wholesale product delivery, retail services, marketing programs and business advisory services 3. The retail footprint allows for good growth. 5. Its subsidiaries include Priceline, Priceline Pharmacy, Soul Pattinson, Pharmacists Advice |
| Australian Pharmaceutical Industries Weaknesses |
Here are the weaknesses in the Australian Pharmaceutical Industries SWOT Analysis: 1. Alleged accounting discrepancies & Sigma takeover controversies affected the brand 2. The company may lose focus if they enter into different segments (personal care, well-being products) all together 3. The market is dominated (90% of market) by 3 major players – API, Sigma, and Symbion Health; gaining more market share is a difficult task |
| Australian Pharmaceutical Industries Opportunities |
Following are the Opportunities in Australian Pharmaceutical Industries SWOT Analysis: 1. Awareness about healthcare is rapidly increasing, API has a huge space to come up with healthcare and well-being products 2. It can divest pharmaceutical assets which could help the company in increasing its focus on core business 3.There is scope for development in areas of well-being and personal care. |
| Australian Pharmaceutical Industries Threats |
The threats in the SWOT Analysis of Australian Pharmaceutical Industries are as mentioned: 1. Reforms in pharmaceutical pricing scheme namely PBS reforms can create trouble for the company 2. The margins of the company may be hurt because of PBS because it may create a trade barrier between Australian and U.S. drug companies 3. Stringent rules against clinical trials and quality of drugs will require more stringent measures from the company leading to increased costs |
| Australian Pharmaceutical Industries Competition | |
| Australian Pharmaceutical Industries Competitors |
Below are the top 3 competitors of Australian Pharmaceutical Industries: 2. Symbion Health 3. Alphapharm |
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Australian Pharmaceutical Industries. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
